Analysis of Insider Transactions and Q1 Performance at Iradimed Corp (NASDAQ: IRMD)
Iradimed Corp's CEO, Roger E. Susi, executed indirect sales of company common stock totaling $657,264. These transactions occurred between May 18 and May 19, 2026. Separately, the company announced first-quarter 2026 earnings that surpassed analyst forecasts for both earnings per share and revenue, although the stock saw a subsequent decline in pre…